ACE inhibitors/ARBs* in high risk patients (*ACE inhibitors – angiotensin converting enzyme inhibitors and ARBs – angiotensin-receptor blockers)

At this time, there is no known scientific evidence for a connection between ACE-I or ARBs and risk of contracting or increased severity of COVID-19. Patients who rely on ACE-I or ARBs to treat chronic conditions and have questions, should speak to their provider for individualized management. key words: medication, angiotensin, receptor, blockers, inhibitors, enzyme, chronic

SNOMED_CT Problem=191415002 (PB0050); SNOMED_CT Cat-Tar=409022004 (CG0003, TG0073)

  • medication coordination/ordering

Back